Literature DB >> 2680345

Changes in hyaluronan concentration in tissues and body fluids in disease states.

A Engström-Laurent1.   

Abstract

Proteins which specifically bind hyaluronan have been used to develop sensitive immunoassay-like analytical techniques. These assays have made it possible to analyse hyaluronan concentrations in nanogram amounts in tissues and body fluids. The normal adult human circulating level of hyaluronan varies between 10 and 100 micrograms/l. Increased levels of serum hyaluronan (greater than 1 mg/l) have been found in inflammatory rheumatic diseases such as rheumatoid arthritis, scleroderma and psoriatic arthritis. Even higher levels occur in serum from patients with cirrhotic liver diseases and in patients with malignant mesothelioma. Elevated serum hyaluronan levels are a sign either of increased production and/or outflow from the tissues or of decreased elimination of the polysaccharide in the liver endothelial cells or in other parts of the reticuloendothelial system or through the kidneys. The serum concentration is also influenced by increased age and by the degree of physical activity. Important information on pathological processes has been gained by analysing the hyaluronan concentration in other body fluids such as urine, perfusion fluid from the intestine and bronchoalveolar lavage fluid. In the future these analyses should also be useful in clinical work.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2680345     DOI: 10.1002/9780470513774.ch14

Source DB:  PubMed          Journal:  Ciba Found Symp        ISSN: 0300-5208


  12 in total

1.  Proinflammatory stimuli regulate endothelial hyaluronan expression and CD44/HA-dependent primary adhesion.

Authors:  M Mohamadzadeh; H DeGrendele; H Arizpe; P Estess; M Siegelman
Journal:  J Clin Invest       Date:  1998-01-01       Impact factor: 14.808

2.  Serum hyaluronan levels increase with the total number of osteoarthritic joints and are strongly associated with the presence of knee and finger osteoarthritis.

Authors:  Eiji Sasaki; Eiichi Tsuda; Yuji Yamamoto; Koei Iwasaki; Ryo Inoue; Ippei Takahashi; Kaori Sawada; Hiroshi Fujita; Takashi Umeda; Shigeyuki Nakaji; Yasuyuki Ishibashi
Journal:  Int Orthop       Date:  2013-03-19       Impact factor: 3.075

Review 3.  Hyaluronan fragments as mediators of inflammation in allergic pulmonary disease.

Authors:  Sumit Ghosh; Scott A Hoselton; Glenn P Dorsam; Jane M Schuh
Journal:  Immunobiology       Date:  2014-12-31       Impact factor: 3.144

Review 4.  Hyaluronan homeostasis and its role in pain and muscle stiffness.

Authors:  Adam Amir; Soo Kim; Antonio Stecco; Michael P Jankowski; Preeti Raghavan
Journal:  PM R       Date:  2022-01-25       Impact factor: 2.218

5.  Cytokine regulation of human lung fibroblast hyaluronan (hyaluronic acid) production. Evidence for cytokine-regulated hyaluronan (hyaluronic acid) degradation and human lung fibroblast-derived hyaluronidase.

Authors:  P M Sampson; C L Rochester; B Freundlich; J A Elias
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

6.  Endocytosis of hyaluronan in rat Kupffer cells.

Authors:  J Alston-Smith; H Pertoft; T C Laurent
Journal:  Biochem J       Date:  1992-09-01       Impact factor: 3.857

7.  Hyaluronan and CD44 in psoriatic skin. Intense staining for hyaluronan on dermal capillary loops and reduced expression of CD44 and hyaluronan in keratinocyte-leukocyte interfaces.

Authors:  R Tammi; K Paukkonen; C Wang; M Horsmanheimo; M Tammi
Journal:  Arch Dermatol Res       Date:  1994       Impact factor: 3.017

8.  Type VI collagen microfibrils: evidence for a structural association with hyaluronan.

Authors:  C M Kielty; S P Whittaker; M E Grant; C A Shuttleworth
Journal:  J Cell Biol       Date:  1992-08       Impact factor: 10.539

9.  LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan.

Authors:  S Banerji; J Ni; S X Wang; S Clasper; J Su; R Tammi; M Jones; D G Jackson
Journal:  J Cell Biol       Date:  1999-02-22       Impact factor: 10.539

Review 10.  The need for prognosticators in rheumatoid arthritis. Biological and clinical markers: where are we now?

Authors:  Josef S Smolen; Daniel Aletaha; Johannes Grisar; Kurt Redlich; Günter Steiner; Oswald Wagner
Journal:  Arthritis Res Ther       Date:  2008-05-29       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.